Testing the validity and responsiveness of a new cancer-specific health utility measure (FACT-8D) in relapsed/refractory mantle cell lymphoma, and comparison to EQ-5D-5L. [electronic resource]
- Journal of patient-reported outcomes Mar 2020
- 22 p. digital